GCB-002

· Genecombio Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GCB-002, covering 2025-03-11 to 2025-03-11. Get the full timeline:

Most recent: Clinical Trial Update: GCB-002 in Treatment of Patients With Rett Syndrome [NA]